A team of Swedish researchers recruited 30 patients for this split-mouth, single-masked, randomized, controlled clinical trial. They randomly assigned the mandibular left or right side as the test ...
– The first-in-human clinical study of SRP-1005, known as INSIGHTT, is expected to begin in the second quarter of 2026 INSIGHTT is a Phase 1, multi-center, dose escalation study that will evaluate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results